Please join us at the historic Bath Guidhall to listen to Professor Francesca Aweeka one Bath's 2023/24 Global Chairs hosted by the Department of Life Sciences.

More information, including the lecture title and abstract to follow shortly.

Biography

With more than 35 years experience as a clinical pharmacologist, Professor Francesca Aweeka's work has enabled a better understanding of the clinical pharmacology and treatments of several global health diseases, most notably malaria, HIV and most recently, COVID-19. Prof Aweeka previously served as the Chair of the Pharmacology Committee of the NIH-based AIDS Clinical Trials Group and served as the Director of the internationally regarded Drug Research Unit (DRU) at the University of California, San Francisco for >20 years.

Professor Aweeka's research is primarily focused on anti-infective drugs, specifically in resource-limited settings such as sub-Saharan Africa. Her work has significantly contributed to the optimization of anti-retroviral drug therapies for the treatment of HIV.

Through her mentorship of students, trainees and early career researchers at UCSF and, most notably, in sub-Saharan Africa, Prof Aweeka has made major contributions to diversity, equity and inclusion. She is Principal Investigator for multiple grants funded by the US National Institute of Health that focus on improving treatments for vulnerable populations in Uganda and as part of a UCSF School of Pharmacy initiative, she is collaborating with the University of Nigeria to develop curricula for their School of Pharmacy program.